Business
Prelude Therapeutics Inc (NASDAQ: PRLD) Stock: Does It Have More Upside?
In the last trading session, 1.04 million shares of the Prelude Therapeutics Inc (NASDAQ:PRLD) were traded, and its beta was 1.58. Most recently the company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
